GeoVax Labs (GOVX) Operating Expenses (2010 - 2026)
GeoVax Labs (GOVX) posted quarterly Operating Expenses of $4.4 million for Q2 2026, down 29.17% year-over-year from $6.3 million in Q2 2025, and little changed quarter-over-quarter from $4.4 million in Q4 2025.
GeoVax Labs (GOVX) Operating Expenses (2010 - 2026) Analysis & Trends
GeoVax Labs (GOVX) has reported Operating Expenses for 17 consecutive years, with $4.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Expenses fell 29.17% year-over-year to $4.4 million; the TTM figure through Jun 2026 stood at $21.5 million (down 30.92% YoY), while the FY2025 annual figure was $24.1 million, down 17.08% from the prior year.
- Operating Expenses steadied at $4.4 million in Q2 2026 per GOVX's latest filing, from $4.4 million in the prior quarter.
- Across five years, Operating Expenses topped out at $9.2 million in Q4 2024 and bottomed at $2.2 million in Q2 2022.
- Historically, Operating Expenses has averaged $5.8 million across 5 years, with a median of $5.9 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Expenses plunged 61.27% — and 2023, when it soared 175.53%.
- GeoVax Labs' Operating Expenses stood at $5.4 million in 2022, then surged by 42.81% to $7.7 million in 2023, then rose by 19.69% to $9.2 million in 2024, then slumped by 51.77% to $4.4 million in 2025, then gained by 0.01% to $4.4 million in 2026.
- Business Quant data shows GOVX's Operating Expenses at $4.4 million in Q2 2026, $4.4 million in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - | 4.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.44 Mn |
| Dec 31, 2025 | 4.44 Mn |
| Sep 30, 2025 | 6.37 Mn |
| Jun 30, 2025 | 6.27 Mn |
| Mar 31, 2025 | 7.04 Mn |
| Dec 31, 2024 | 9.21 Mn |
| Sep 30, 2024 | 8.64 Mn |
| Jun 30, 2024 | 5.36 Mn |
| Mar 31, 2024 | 5.88 Mn |
| Dec 31, 2023 | 7.69 Mn |
| Sep 30, 2023 | 8.60 Mn |
| Jun 30, 2023 | 6.18 Mn |
| Mar 31, 2023 | 4.27 Mn |
| Dec 31, 2022 | 5.39 Mn |
| Sep 30, 2022 | 3.97 Mn |
| Jun 30, 2022 | 2.24 Mn |
| Mar 31, 2022 | 2.51 Mn |
| Dec 31, 2021 | 13.91 Mn |
| Sep 30, 2021 | 1.98 Mn |
| Jun 30, 2021 | 1.57 Mn |